Clinical Trial Update: Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) [Phase 4]

View source ↗

Summary

Phase 4 study assessing safety and efficacy of the Antihemophilic Factor/Von Willebrand Factor Complex in surgical subjects with von Willebrand disease has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• Humate-P (Antihemophilic Factor/Von Willebrand Factor Complex)

Snippet

Sponsor: CSL Behring | Conditions: Von Willebrand Disease, Blood Coagulation Disorders | Phase 4 | Status: COMPLETED